← SynDRA
MK-2461
SynDRA canonical compound SYN0027717 — structure-anchored drug synonym record
| Clinical phase | Phase 1/Phase 2 |
|---|
| Primary target(s) | MET |
|---|
| Mechanism of action | VEGFR inhibitor |
|---|
All known targets
- MET
- FGFR1
- FGFR2
- FGFR3
- FLT1
- FLT3
- FLT4
- KDR
- MERTK
- MST1R
- NTRK2
- PDGFRB
Mechanisms of action (all sources)
- FGFR inhibitor
- VEGFR inhibitor
- MET INHIBITOR
- Hepatocyte growth factor receptor inhibitor
- FLT4 INHIBITOR
- MERTK INHIBITOR
- FLT3 INHIBITOR
- FGFR1 INHIBITOR
- PDGFRB INHIBITOR
- KDR INHIBITOR
- FLT1 INHIBITOR
- FGFR3 INHIBITOR
Cross-references
Synonyms
- MK 2461
- MK2461
- UNII-4200RD53XF
- RefChem:159191
- C24H25N5O5S
- JGEBLDKNWBUGRZ-HXUWFJFHSA-N
- SCHEMBL93526
- GTPL7962
- orb1689093
- SCHEMBL29356324
- SCHEMBL29394185
- SCHEMBL29529144
- CHEBI:230540
- GLXC-90441
- EX-A1566
- SLB87939
- BDBM50347659
- MFCD11977739
- NSC764580
- NSC800795
- s2774
- AKOS027282698
- CCG-264723
- CS-5537
- NSC-764580
- NSC-800795
- SDCCGSBI-0654470.P001
- NCGC00346695-01
- NCGC00346695-02
- NCGC00346695-03
- NCGC00346695-05
- AC-32072
- AS-16288
- DA-65500
- HY-50703
- M4004
- SW219905-1
- T6094
Look up MK-2461 in the interactive SynDRA portal →